Heteronuclear MRI offers broad potential for specific detection and quantification of molecularly targeted agents in diagnosis and therapy planning or monitoring. Here we report a novel method for simultaneous acquisition of dual-nuclei hyper-CEST 129Xe and 19F tumor targeting MRI. 129Xe hyper-CEST MRI, 19F MRI and fluorescent imaging were integrated into PFOB nanoemulsion as a imaging system for sensitive and selective tumor cells detection. As the complement to 1H MRI, 129Xe and 19F signals can also provide efficient and precise anatomical localization of tumors.
Keywords: 129Xe MRI; 19F MRI; hyper-CEST; nanoemulsion; tumor.